Diagnostic delay stages and pre-diagnostic treatment in patients with suspected rheumatic diseases before special care consultation: results of a multicenter-based study
- PMID: 36214864
- PMCID: PMC9968271
- DOI: 10.1007/s00296-022-05223-z
Diagnostic delay stages and pre-diagnostic treatment in patients with suspected rheumatic diseases before special care consultation: results of a multicenter-based study
Abstract
Early and effective discrimination (triage) of patients with inflammatory rheumatic diseases (IRD) and other diseases (non-IRD) is essential for successful treatment and preventing damage. The aim of this study was to investigate diagnostic delays and pre-diagnosis treatment in patients newly presenting to rheumatology outpatient clinics. A total of 600 patients newly presenting to one university hospital and two non-academic centers were included. Time from onset of symptoms to rheumatology consultation "total delay" as well as medical treatment before consultation were recorded. Median time from symptom onset to rheumatologist appointment (total delay) was 30 weeks. Median time to online search, first physician appointment request and first physician appointment was 2, 4 and 5 weeks, respectively. Total delay was significantly shorter for IRD patients compared to non-IRD patients, 26 vs 35 weeks (p = 0.007). Only 17.7% of all patients and 22.9% of IRD patients had a delay of less than 12 weeks. Total delay was significantly lower in patients seen in non-academic centers compared to the university center, 20 vs 50 weeks (p < 0.0001). 32.2% of IRD patients received medical treatment that eased their symptoms prior to the rheumatology appointment. These findings highlight the persistent diagnostic delays in rheumatology; however, they also suggest that current triage strategies effectively lead to earlier appointments for IRD patients. Improvement of triage methods and pre-diagnosis treatment could decrease overall burden of disease in IRD patients.
Keywords: Delayed diagnosis; Diagnostic delay; Health service research; Outcome research; Time to therapy; Triage.
© 2022. The Author(s).
Conflict of interest statement
JK has received research support from Novartis Pharma GmbH.
Figures


Similar articles
-
Patterns of Care Among Patients Referred to Rheumatologists in Ontario, Canada.Arthritis Care Res (Hoboken). 2017 Jan;69(1):104-114. doi: 10.1002/acr.22910. Epub 2016 Nov 16. Arthritis Care Res (Hoboken). 2017. PMID: 27110847
-
Diagnostic Accuracy of a Mobile AI-Based Symptom Checker and a Web-Based Self-Referral Tool in Rheumatology: Multicenter Randomized Controlled Trial.J Med Internet Res. 2024 Jul 23;26:e55542. doi: 10.2196/55542. J Med Internet Res. 2024. PMID: 39042425 Free PMC article. Clinical Trial.
-
[Improved early diagnostics of rheumatic diseases : Monocentric experiences with an open rheumatological specialist consultation].Z Rheumatol. 2018 Nov;77(9):844-849. doi: 10.1007/s00393-018-0540-4. Z Rheumatol. 2018. PMID: 30255411 Review. German.
-
RhePort 1.3 enhances early identification of inflammatory rheumatic diseases: a prospective study in German rheumatology settings.Rheumatol Int. 2025 Apr 28;45(5):129. doi: 10.1007/s00296-025-05861-z. Rheumatol Int. 2025. PMID: 40293492 Free PMC article. Clinical Trial.
-
[Transition in pediatric rheumatology-experiences from the pediatric rheumatism center Sankt Augustin].Z Rheumatol. 2018 Oct;77(8):677-684. doi: 10.1007/s00393-018-0511-9. Z Rheumatol. 2018. PMID: 30043177 Review. German.
Cited by
-
Between uncertainty and destiny: the patient journey in axial spondyloarthritis care from the perspectives of patients and their relatives.BMC Rheumatol. 2025 Feb 12;9(1):14. doi: 10.1186/s41927-025-00465-3. BMC Rheumatol. 2025. PMID: 39934914 Free PMC article.
-
["Rheuma (be-)greifen"- A multimodal teaching concept to improve rheumatology education for medical students].Z Rheumatol. 2024 Apr;83(3):186-193. doi: 10.1007/s00393-023-01391-w. Epub 2023 Jul 28. Z Rheumatol. 2024. PMID: 37505294 Free PMC article. German.
-
Back on track - digital health applications to treat back pain of rheumatic patients? Results of a qualitative interview study.Rheumatol Int. 2024 Dec;44(12):2977-2987. doi: 10.1007/s00296-024-05726-x. Epub 2024 Sep 28. Rheumatol Int. 2024. PMID: 39340666 Free PMC article.
-
Barriers and facilitators associated with diagnostic and treatment delays in lupus in the Global South and North: a systematic review of qualitative and mixed methods studies.Rheumatol Int. 2025 Apr 25;45(5):121. doi: 10.1007/s00296-025-05875-7. Rheumatol Int. 2025. PMID: 40278884
-
[Rheumatological care in Germany : Memorandum of the German Society for Rheumatology and Clinical Immunology 2024].Z Rheumatol. 2024 Aug;83(Suppl 2):249-284. doi: 10.1007/s00393-024-01539-2. Epub 2024 Aug 13. Z Rheumatol. 2024. PMID: 39136764 German.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources